Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2597 Views
-
Last post by NHE
-
- 0 Replies
- 561 Views
-
Last post by NHE
-
- 6 Replies
- 7944 Views
-
Last post by ElliotB
-
- 0 Replies
- 3825 Views
-
Last post by NHE
-
- 0 Replies
- 1429 Views
-
Last post by NHE
-
- 0 Replies
- 749 Views
-
Last post by NHE
-
- 0 Replies
- 3511 Views
-
Last post by NHE
-
- 11 Replies
- 3539 Views
-
Last post by NHE
-
- 1 Replies
- 1168 Views
-
Last post by NHE